Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease
T regulatory cell therapy presents a novel therapeutic strategy for patients with autoimmune diseases or who are undergoing transplantation. At present, the CD4<sup>+</sup> Treg population has been extensively characterized, as a result of defined phenotypic and functional readouts. In t...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c8f856cc5e947cdb4c5cf8bd03897b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0c8f856cc5e947cdb4c5cf8bd03897b0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0c8f856cc5e947cdb4c5cf8bd03897b02021-11-25T17:09:55ZHarnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease10.3390/cells101129732073-4409https://doaj.org/article/0c8f856cc5e947cdb4c5cf8bd03897b02021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2973https://doaj.org/toc/2073-4409T regulatory cell therapy presents a novel therapeutic strategy for patients with autoimmune diseases or who are undergoing transplantation. At present, the CD4<sup>+</sup> Treg population has been extensively characterized, as a result of defined phenotypic and functional readouts. In this review article, we discuss the development and biology of CD8<sup>+</sup> Tregs and their role in murine and human disease indications. A subset of CD8<sup>+</sup> Tregs that lack the surface expression of CD28 (CD8<sup>+</sup>CD28<sup>−</sup> Treg) has proved efficacious in preclinical models. CD8<sup>+</sup>CD28<sup>−</sup> Tregs are present in healthy individuals, but their impaired functionality in disease renders them less effective in mediating immunosuppression. We primarily focus on harnessing CD8<sup>+</sup> Treg cell therapy in the clinic to support current treatment for patients with autoimmune or inflammatory conditions.Sabrina CeerazCharlotte R. ThompsonRichard BeatsonErnest H. ChoyMDPI AGarticleCD8TregautoimmunityimmunoregulationBiology (General)QH301-705.5ENCells, Vol 10, Iss 2973, p 2973 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CD8 Treg autoimmunity immunoregulation Biology (General) QH301-705.5 |
spellingShingle |
CD8 Treg autoimmunity immunoregulation Biology (General) QH301-705.5 Sabrina Ceeraz Charlotte R. Thompson Richard Beatson Ernest H. Choy Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
description |
T regulatory cell therapy presents a novel therapeutic strategy for patients with autoimmune diseases or who are undergoing transplantation. At present, the CD4<sup>+</sup> Treg population has been extensively characterized, as a result of defined phenotypic and functional readouts. In this review article, we discuss the development and biology of CD8<sup>+</sup> Tregs and their role in murine and human disease indications. A subset of CD8<sup>+</sup> Tregs that lack the surface expression of CD28 (CD8<sup>+</sup>CD28<sup>−</sup> Treg) has proved efficacious in preclinical models. CD8<sup>+</sup>CD28<sup>−</sup> Tregs are present in healthy individuals, but their impaired functionality in disease renders them less effective in mediating immunosuppression. We primarily focus on harnessing CD8<sup>+</sup> Treg cell therapy in the clinic to support current treatment for patients with autoimmune or inflammatory conditions. |
format |
article |
author |
Sabrina Ceeraz Charlotte R. Thompson Richard Beatson Ernest H. Choy |
author_facet |
Sabrina Ceeraz Charlotte R. Thompson Richard Beatson Ernest H. Choy |
author_sort |
Sabrina Ceeraz |
title |
Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
title_short |
Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
title_full |
Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
title_fullStr |
Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
title_full_unstemmed |
Harnessing CD8<sup>+</sup>CD28<sup>−</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease |
title_sort |
harnessing cd8<sup>+</sup>cd28<sup>−</sup> regulatory t cells as a tool to treat autoimmune disease |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/0c8f856cc5e947cdb4c5cf8bd03897b0 |
work_keys_str_mv |
AT sabrinaceeraz harnessingcd8supsupcd28supsupregulatorytcellsasatooltotreatautoimmunedisease AT charlotterthompson harnessingcd8supsupcd28supsupregulatorytcellsasatooltotreatautoimmunedisease AT richardbeatson harnessingcd8supsupcd28supsupregulatorytcellsasatooltotreatautoimmunedisease AT ernesthchoy harnessingcd8supsupcd28supsupregulatorytcellsasatooltotreatautoimmunedisease |
_version_ |
1718412633062768640 |